Appili Therapeutics

📍 Halifax, Canada🗓 Founded 2015👥 15 employees💰 Last funded May 2019
Biotechnology Research🌐 appilitherapeutics.com
Website LinkedIn
Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
2
Frequently asked questions
Who invested in Appili Therapeutics?
Appili Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Appili Therapeutics last raise funding?
The most recent investment in Appili Therapeutics recorded on gritt.io was in May 2019.
When was Appili Therapeutics founded?
Appili Therapeutics was founded in 2015.
What industry is Appili Therapeutics in?
Appili Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Appili Therapeutics based?
Appili Therapeutics is headquartered in Halifax, Canada.